Clinical Trial Update: High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating high-dose rifampicin for tuberculous meningitis to determine the optimal dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculous Meningitis

Drugs mentioned

• Rifampicin

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Tuberculosis, Meningeal | Phase 2, Phase 3 | Status: COMPLETED